Nutritional Risk Screening 2002 As A Nutritional Risk Screening Method in Esophageal Cancer Patients Treated with Radiation Therapy

B. Yu,J. Wang,S. Xie,Y. Ye,Y. Xu,M. Chen

DOI: https://doi.org/10.1016/j.ijrobp.2015.07.947

2015-01-01

Abstract:To assess the value of nutritional risk screening-2002 (NRS-2002) as a nutritional risk screening method in esophageal cancer patients treated with radiation therapy. A total of 97 esophageal cancer patients previously treated with radiation therapy at a Cancer Hospital were selected for the present study. Nutritional status was assessed by NRS-2002. Weight, serum total protein, albumin, prealbumin level, red blood cell and hemoglobin were also recorded. Patients at nutritional risk based on NRS-2002 from to increased form 26.8% (/97) at baseline to 44.8%(/97) at the 6th week of radiation therapy. In univariate analysis, NRS-2002 score≤3 at baseline was associated with improved 1-year overall survival (OS) than NRS-2002 score≥4 (91.3% vs. 61.9%, P=0.015). The max NRS-2002 score≤2 during treatment was associated with improved 1-year OS than NRS-2002 cut-off ≥3 (94.2% vs. 77.5%, P=0.014). The min NRS-2002 score≤3 during treatment was associated with improved 1-year OS than NRS-2002 score≥4 (65.3% vs. 27.3%, P=0.01). NRS-2002 score correlated negatively with prealbumin at baseline and the 1st week of radiation therapy (r2=5.951, P=0.000; r2=4.683, P=0.002). The NRS2002 score correlated negatively with albumin at the 3rd week of radiation therapy (r2=2.690, P=0.036). Multivariate analyses showed patients with earlier TMN stage or lower max NRS-2002 score during treatment had better survival outcomes. NRS-2002 was a reliable nutritional risk screening method in esophageal cancer patients treated with radiation therapy.